These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33960279)

  • 21. Mannan-conjugated myelin peptides prime non-pathogenic Th1 and Th17 cells and ameliorate experimental autoimmune encephalomyelitis.
    Tseveleki V; Tselios T; Kanistras I; Koutsoni O; Karamita M; Vamvakas SS; Apostolopoulos V; Dotsika E; Matsoukas J; Lassmann H; Probert L
    Exp Neurol; 2015 May; 267():254-67. PubMed ID: 25447934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PIK3C3/VPS34, the class III PtdIns 3-kinase, plays indispensable roles in the podocyte.
    Chen JK
    Autophagy; 2013 Jun; 9(6):923-4. PubMed ID: 23518611
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroantigen-specific autoregulatory CD8+ T cells inhibit autoimmune demyelination through modulation of dendritic cell function.
    Kashi VP; Ortega SB; Karandikar NJ
    PLoS One; 2014; 9(8):e105763. PubMed ID: 25144738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C-Reactive Protein Suppresses the Th17 Response Indirectly by Attenuating the Antigen Presentation Ability of Monocyte Derived Dendritic Cells in Experimental Autoimmune Encephalomyelitis.
    Shen ZY; Zheng Y; Pecsok MK; Wang K; Li W; Gong MJ; Wu F; Zhang L
    Front Immunol; 2021; 12():589200. PubMed ID: 33841391
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis.
    Tompkins SM; Padilla J; Dal Canto MC; Ting JP; Van Kaer L; Miller SD
    J Immunol; 2002 Apr; 168(8):4173-83. PubMed ID: 11937578
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmacytoid DC promote priming of autoimmune Th17 cells and EAE.
    Isaksson M; Ardesjö B; Rönnblom L; Kämpe O; Lassmann H; Eloranta ML; Lobell A
    Eur J Immunol; 2009 Oct; 39(10):2925-35. PubMed ID: 19637225
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Group A
    Toh H; Nozawa T; Minowa-Nozawa A; Hikichi M; Nakajima S; Aikawa C; Nakagawa I
    Autophagy; 2020 Feb; 16(2):334-346. PubMed ID: 31177902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel and conventional inhibitors of canonical autophagy differently affect LC3-associated phagocytosis.
    Stempels FC; Janssens MH; Ter Beest M; Mesman RJ; Revelo NH; Ioannidis M; van den Bogaart G
    FEBS Lett; 2022 Feb; 596(4):491-509. PubMed ID: 35007347
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Divergent roles of BECN1 in LC3 lipidation and autophagosomal function.
    He R; Peng J; Yuan P; Xu F; Wei W
    Autophagy; 2015; 11(5):740-7. PubMed ID: 25955014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PIK3C3/VPS34 control by acetylation.
    Su H; Liu W
    Autophagy; 2018; 14(6):1086-1087. PubMed ID: 28980854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of in vitro PIK3C3/VPS34 complex protein assay for autophagy-specific inhibitor screening.
    Kim TM; Baek JH; Kim JH; Oh MS; Kim J
    Anal Biochem; 2015 Jul; 480():21-7. PubMed ID: 25862085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The autoimmune reactivity to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis is potentially pathogenic: effect of copolymer 1 on MOG-induced disease.
    Ben-Nun A; Mendel I; Bakimer R; Fridkis-Hareli M; Teitelbaum D; Arnon R; Sela M; Kerlero de Rosbo N
    J Neurol; 1996 Apr; 243(4 Suppl 1):S14-22. PubMed ID: 8965116
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Targeting of Immune Cell Autophagy in Multiple Sclerosis: Russian Roulette or Silver Bullet?
    Yang G; Van Kaer L
    Front Immunol; 2021; 12():724108. PubMed ID: 34531871
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis.
    Pennell LM; Fish EN
    Immunology; 2017 Nov; 152(3):439-450. PubMed ID: 28646573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting autophagy in disease: established and new strategies.
    Kocak M; Ezazi Erdi S; Jorba G; Maestro I; Farrés J; Kirkin V; Martinez A; Pless O
    Autophagy; 2022 Mar; 18(3):473-495. PubMed ID: 34241570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An IL-23-STAT4 pathway is required for the proinflammatory function of classical dendritic cells during CNS inflammation.
    Alakhras NS; Zhang W; Barros N; Sharma A; Ropa J; Priya R; Yang XF; Kaplan MH
    Proc Natl Acad Sci U S A; 2024 Aug; 121(32):e2400153121. PubMed ID: 39088391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE.
    Isaksson M; Lundgren BA; Ahlgren KM; Kämpe O; Lobell A
    Eur J Immunol; 2012 Oct; 42(10):2555-63. PubMed ID: 22806332
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemokine CCL17 is expressed by dendritic cells in the CNS during experimental autoimmune encephalomyelitis and promotes pathogenesis of disease.
    Ruland C; Renken H; Kuzmanov I; Fattahi Mehr A; Schwarte K; Cerina M; Herrmann A; Otte DM; Zimmer A; Schwab N; Meuth SG; Arolt V; Klotz L; Förster I; Scheu S; Alferink J
    Brain Behav Immun; 2017 Nov; 66():382-393. PubMed ID: 28642092
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autophagy protein ATG5 regulates CD36 expression and anti-tumor MHC class II antigen presentation in dendritic cells.
    Oh DS; Lee HK
    Autophagy; 2019 Dec; 15(12):2091-2106. PubMed ID: 30900506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of dendritic cells in CNS autoimmunity.
    Zozulya AL; Clarkson BD; Ortler S; Fabry Z; Wiendl H
    J Mol Med (Berl); 2010 Jun; 88(6):535-44. PubMed ID: 20217033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.